Covered recipient · General Payments record
SARA L BARRETT
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2025
$2,655.79
- Reported across 149 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $671.05 | 34 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $305.77 | 17 |
| Gilead Sciences, Inc. | $72.57 | 4 |
| Phathom Pharmaceuticals, Inc. | $62.69 | 1 |
| PFIZER INC. | $55.45 | 3 |
| INTERCEPT PHARMACEUTICALS, INC. | $43.03 | 2 |
| Madrigal Pharmaceuticals | $41.94 | 2 |
| Ardelyx, Inc. | $29.62 | 2 |
| QOL Medical, LLC | $22.98 | 1 |
| Ipsen Biopharmaceuticals, Inc | $19.28 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2025 2021202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.65 | 01/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1205068170 | CMS |
| ABBVIE INC. | $5.52 | 02/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1205068176 | CMS |
| ABBVIE INC. | $2.82 | 02/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1205068182 | CMS |
| ABBVIE INC. | $16.18 | 03/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1205068188 | CMS |
| ABBVIE INC. | $23.52 | 04/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1205068195 | CMS |
| ABBVIE INC. | $113.71 | 04/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1205068200 | CMS |
| ABBVIE INC. | $22.26 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1205068205 | CMS |
| ABBVIE INC. | $4.47 | 06/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1205068211 | CMS |
| ABBVIE INC. | $17.18 | 06/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1205068216 | CMS |
| ABBVIE INC. | $4.49 | 07/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1205068223 | CMS |
| ABBVIE INC. | $3.98 | 07/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1205068227 | CMS |
| ABBVIE INC. | $3.89 | 08/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1205068233 | CMS |
| ABBVIE INC. | $5.29 | 08/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1205068238 | CMS |
| ABBVIE INC. | $16.88 | 08/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1205068244 | CMS |
| ABBVIE INC. | $16.35 | 10/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1205068250 | CMS |
| ABBVIE INC. | $10.53 | 11/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1205068256 | CMS |
| ABBVIE INC. | $19.05 | 12/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1205068260 | CMS |
| Ardelyx, Inc. | $14.50 | 11/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247898727 | CMS |
| Ardelyx, Inc. | $15.12 | 11/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247898729 | CMS |
| Gilead Sciences, Inc. | $17.69 | 02/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234551833 | CMS |
| Gilead Sciences, Inc. | $19.47 | 03/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234533951 | CMS |
| Gilead Sciences, Inc. | $18.33 | 05/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234545835 | CMS |
| Gilead Sciences, Inc. | $17.08 | 08/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234557191 | CMS |
| Intercept Pharmaceuticals, Inc. | $24.38 | 06/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249886353 | CMS |
| Intercept Pharmaceuticals, Inc. | $18.65 | 09/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249886355 | CMS |
| Ipsen Biopharmaceuticals, Inc | $19.28 | 06/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1208856647 | CMS |
| Madrigal Pharmaceuticals | $19.36 | 09/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248328929 | CMS |
| Madrigal Pharmaceuticals | $22.58 | 12/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248328931 | CMS |
| PFIZER INC. | $18.36 | 10/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230442484 | CMS |
| PFIZER INC. | $17.86 | 11/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230870712 | CMS |
| PFIZER INC. | $19.23 | 12/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230889108 | CMS |
| Phathom Pharmaceuticals, Inc. | $62.69 | 04/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1219223556 | CMS |
| QOL Medical, LLC | $22.98 | 11/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1185027056 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.72 | 03/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223996161 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.